Illustrated research building at dusk, laboratory below and library above

Emerging Biotech

Shape the trial that defines your company’s next chapter

Bring evidence, reasoning and action to the decisions that shape your pivotal study and your runway.

Put your science and your runway to work with Altrovia

Evidence

Build conviction in the design behind your next milestone

Explore endpoints, eligibility and statistical approaches against comparable trials and regulatory precedent. Altrovia connects every design question to evidence your team can inspect, challenge, and act on. Give your team a clear rationale to bring into advisor, partner and regulatory discussions.

Optimization

Make your runway go further through thoughtful design

Examine how many participants, sites and assessments your scientific question requires. Compare design alternatives against comparable studies and amendment patterns before committing resources. Focus spending on the evidence your next readout needs, helping preserve capital for the steps that follow.

Ownership

Set the direction before your partners get to work

Bring your CRO and advisors a protocol with clear endpoints, eligibility and rationale. Your team can refine the design together, with every decision owned and approved in one place. A clear plan gives your company a stronger foundation for discussing delivery, timelines and budget.

Case study: Phase 2 study design

A focused study can create more room in your budget

In one biotech sponsor’s Phase 2 engagement, Altrovia benchmarked site needs and enrollment against comparable studies and recalculated sample size for 90% power on the primary endpoint. The revised plan required fewer sites and participants while retaining the target statistical power.

27.3%

Fewer planned sites

55 → 40
18.8%

Lower planned enrollment

160 → 130 participants
90%

Statistical power in the revised calculation

For the primary endpoint

Fifteen fewer sites to activate and thirty fewer participants to enroll meant a smaller operational plan to fund and coordinate.

Results from one study-design engagement. Percentages compare initial and revised plans, not total trial costs. Actual costs and outcomes depend on execution and study assumptions.

Bring your company’s knowledge into every workflow

Connect your protocol, supporting evidence and recorded decisions. Altrovia combines them with public trial data so agents work from your company’s context, and the design and the reasoning behind it stay together for board, investor and partner conversations.

Your company / Data sourcesPrivate to your team
  • Your protocolConnected
  • Supporting evidenceConnected
  • Recorded decisionsConnected

From conversations with biotech teams

“Every amendment takes months out of our timeline. We’ve come to treat that as part of running a trial.”
Biotech, Clinical Lead
“Finding and comparing relevant studies is still manual work, and it slows down protocol development.”
Biotech, Senior Clinical Trial Manager
“We have tools to look at historical enrollment, but no integrated system to help us design the protocol.”
Biotech, Senior Clinical Trial Manager